TRULANCE Drug Profile: TRULANCE (plecanatide) drug patents, FDA exclusivity, litigation, drug prices
TRULANCE Drug Profile: TRULANCE (plecanatide) drug patents, FDA exclusivity, litigation, drug prices
Description :
TRULANCE Drug Profile, 2023This report focuses on TRULANCE and covers the following critical aspects of this drug:United States patentsExpired United States patentsDistrict Court patent litigationPatent Trial and Appeal Board (PTAB) patent casesClinical trialsDrug pricesFinished product suppliersRaw active pharmaceutical ingredient (API) sourcesContentsProfile for TRULANCEUS PatentsExpired US PatentsUS District Court LitigationUS Patent Trial and Appeal Board CasesInternational (exUS) PatentsClinical TrialsDrug Prices - Average Pharmacy CostDrug Prices - Best Wholesale PriceFinished Product SuppliersBulk API SourcesCompanies Mentioned:SALIX PHARMACEUTICALS INC., SYNERGY PHARMACEUTICALS INC., CHEMENU INC., THE BIOTEK, CHEMSPACE.COM DATABASE, SMOLECULE, ABMOLE BIOSCIENCE, TARGETMOL, BENCHCHEM, J&HCHEMICAL CO.,LTD,
CYMITQUIMICA, GLIXX LABS INC, STARSHINE CHEMICALCountries
Mentioned:United States, Australia, Brazil, Canada, China, Cyprus, Germany, Denmark, Spain, Hong Kong, Israel, Japan, South Korea, Portugal